STERIS plc at Morgan Stanley Global Healthcare Conference Transcript
Okay. Good morning, everyone. Thank you so much for being here. Patrick Wood. I run the U.S. Medtech team. I'm very excited to have Dan Carestio here, CEO of STERIS. Before we start, some disclaimers. There's usually a little a board here, so I'm going to ask about memory, morganstanley.com/researchdisclosures. Pretty sure that's the one. I'm sure you're all be going there. Or you can reach out to your Morgan Stanley sales rep either way. It should be good. Dan, thank you so much for joining us. I really appreciate it.
Questions & Answers
Maybe just to jump right into it, last quarter had some very strong capital equipment trends for you guys. Obviously, you came into it with quite a big backlog, but there's still quite a big backlog. Maybe you could just speak to sort of where you're seeing some of the strength, the type of demand, products, the durability, any comments around that?
I think we've been especially strong in sterile
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
